EuroEyes Declares Final Dividend for 2025 Financial Year

EuroEyes International Eye Clinic Limited ( (HK:1846) ) has issued an update.

EuroEyes International Eye Clinic Limited has declared a final ordinary cash dividend of HKD 0.0126 per share for the financial year ended 31 December 2025, payable in Hong Kong dollars. The dividend is subject to shareholder approval on 30 June 2026, with an ex-dividend date of 3 July 2026 and payment scheduled for 24 July 2026.

The announcement underscores the company’s intention to return cash to shareholders following its 2025 financial performance, signaling confidence in its earnings and cash flow. Key entitlement dates, including the book closure from 7 to 8 July 2026 and the record date of 8 July 2026, provide clarity for investors planning around the dividend, while no withholding tax is indicated on the payment.

The most recent analyst rating on (HK:1846) stock is a Hold with a HK$3.00 price target. To see the full list of analyst forecasts on EuroEyes International Eye Clinic Limited stock, see the HK:1846 Stock Forecast page.

More about EuroEyes International Eye Clinic Limited

EuroEyes International Eye Clinic Limited operates in the eye care and ophthalmic services industry, focusing on clinical treatments and procedures related to vision correction. The company serves patients through specialist eye clinics and positions itself in markets where demand for advanced eye surgery and vision-related medical services is growing.

Average Trading Volume: 117,941

Technical Sentiment Signal: Strong Sell

Current Market Cap: HK$860.2M

For a thorough assessment of 1846 stock, go to TipRanks’ Stock Analysis page.